Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
national top stories
novartis
5
×
boston top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
amgen
biogen
deals
deerfield management
eli lilly
gilead sciences
What
medicines
5
×
fda
drug
new
approval
bio
covid
deal
ipo
roundup
acquire
acquisitions
activity
address
agreed
amgen
announced
approvals
approves
billion
biogen
blueprint
brings
cancer
candidates
carries
cash
ceo
certain
cholesterol
clamped
class
collabs
company
compound
daniel
delays
designed
developed
developing
Language
unset
Current search:
novartis
×
medicines
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines